Agios Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Agios Pharmaceuticals, Inc.‘s stocks are currently a part of 143 hedge funds’ portfolios, which represents 95.51% of the total amount of its stocks outstanding. This makes up a total of 57.73M shares of Agios Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 0.18% or 103.83K shares more. As for the holding position changes, 28.67% (41) of current hedge fund investors increased the number of shares held, 38.46% (55) of current holders sold a part of the shares held, and 15.38% (22) closed the holdings completely. 20 hedge funds are new holders of Agios Pharmaceuticals, Inc. stock in Q1 2022, it is 13.99% of total holders.
Hedge funds holding Agios Pharmaceuticals (Q2 2017 – Q1 2022)
| Q2 2017 | 166 |
|---|---|
| Q3 2017 | 170 |
| Q4 2017 | 174 |
| Q1 2018 | 195 |
| Q2 2018 | 212 |
| Q3 2018 | 204 |
| Q4 2018 | 189 |
| Q1 2019 | 196 |
| Q2 2019 | 182 |
| Q3 2019 | 180 |
| Q4 2019 | 191 |
| Q1 2020 | 188 |
| Q2 2020 | 207 |
| Q3 2020 | 203 |
| Q4 2020 | 190 |
| Q1 2021 | 167 |
| Q2 2021 | 176 |
| Q3 2021 | 156 |
| Q4 2021 | 149 |
| Q1 2022 | 143 |
Hedge funds changes in Agios Pharmaceuticals positions (Q2 2017 – Q1 2022)
| Q2 2017 | 28 | 84 | 34 | 15 | 5 |
|---|---|---|---|---|---|
| Q3 2017 | 30 | 60 | 54 | 24 | 2 |
| Q4 2017 | 27 | 68 | 57 | 23 | -1 |
| Q1 2018 | 42 | 82 | 48 | 19 | 4 |
| Q2 2018 | 36 | 83 | 60 | 18 | 15 |
| Q3 2018 | 25 | 70 | 72 | 32 | 5 |
| Q4 2018 | 25 | 80 | 55 | 40 | -11 |
| Q1 2019 | 38 | 79 | 50 | 30 | -1 |
| Q2 2019 | 29 | 67 | 60 | 39 | -13 |
| Q3 2019 | 30 | 72 | 53 | 31 | -6 |
| Q4 2019 | 44 | 88 | 44 | 28 | -13 |
| Q1 2020 | 32 | 57 | 67 | 33 | -1 |
| Q2 2020 | 48 | 65 | 60 | 27 | 7 |
| Q3 2020 | 34 | 79 | 58 | 37 | -5 |
| Q4 2020 | 31 | 62 | 72 | 43 | -18 |
| Q1 2021 | 19 | 58 | 68 | 40 | -18 |
| Q2 2021 | 39 | 48 | 62 | 28 | -1 |
| Q3 2021 | 17 | 42 | 68 | 36 | -7 |
| Q4 2021 | 25 | 46 | 57 | 33 | -12 |
| Q1 2022 | 20 | 41 | 55 | 22 | 5 |
Hedge funds changes in Agios Pharmaceuticals stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 11,083,000 | 17,853,000 |
|---|---|---|
| Q3 2017 | 23,773,000 | 19,638,000 |
| Q4 2017 | 10,189,000 | 15,147,000 |
| Q1 2018 | 23,992,000 | 25,188,000 |
| Q2 2018 | 46,878,000 | 32,975,000 |
| Q3 2018 | 25,067,000 | 19,836,000 |
| Q4 2018 | 42,537,000 | 17,234,000 |
| Q1 2019 | 55,028,000 | 26,753,000 |
| Q2 2019 | 28,646,000 | 22,854,000 |
| Q3 2019 | 8,616,000 | 35,077,000 |
| Q4 2019 | 25,982,000 | 30,384,000 |
| Q1 2020 | 30,253,000 | 23,133,000 |
| Q2 2020 | 28,875,000 | 19,194,000 |
| Q3 2020 | 7,700,000 | 9,957,000 |
| Q4 2020 | 24,217,000 | 32,232,000 |
| Q1 2021 | 33,668,000 | 22,968,000 |
| Q2 2021 | 30,687,000 | 30,694,000 |
| Q3 2021 | 14,127,000 | 17,767,000 |
| Q4 2021 | 6,914,000 | 13,974,000 |
| Q1 2022 | 8,769,000 | 10,067,000 |